The pharmaceutical industry is under growing pressure from a range of environmental
issues, including major losses of revenue owing to patent expirations, increasingly cost-…

We have studied a novel class of DNA sequences that cause DNA polymerases to pause.
These sequences have the central consensus Py-GC and are not necessarily adjacent to …

Background Cachexia and its most visible manifestation, weight loss, represent important
poor prognostic factors for patients with non‐small cell lung cancer. This work examines how …

Background The aim of this study was to conduct a retrospective database analysis to
describe the chemotherapy treatment patterns and outcomes of patients with gastric cancer. …

We have cloned the Escherichia coli fliAZY operon, which contains the fliA gene (the alternative
sigma factor sigma F) and two novel genes, fliZ and fliY. Transcriptional mapping of this …

Objective. To describe real‐world treatment patterns and outcomes for patients with advanced
soft tissue sarcoma (STS) not amenable to surgery or radiotherapy in the United Kingdom, …

Objective Clinical trials have demonstrated improved outcomes for patients with diffuse large
B-cell lymphoma (DLBCL) treated with regimens containing rituximab, but variations in real-…

Background In the RAISE trial, ramucirumab+leucovorin/fluorouracil/irinotecan (FOLFIRI)
improved the median overall survival (mOS) of patients with previously treated metastatic …

Introduction Projecting disease spread is challenging because of the heterogeneous nature
of human interactions, including both natural societal interactions and how they change in …

Background Colorectal cancer is the third most common cause of cancer death in the USA.
It is important to identify patients who may experience poor outcomes from available …